EP 1587911 A2 20051026 - TKTS AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
Title (en)
TKTS AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
Title (de)
TKTS ALS MODIFIKATOREN DES BETA-CATENIN-WEGS UND VERWENDUNGSVERFAHREN
Title (fr)
TRANSCETOLASES MODIFICATRICES DU CHEMIN DE LA BETA-CATENINE, ET MODE D'UTILISATION
Publication
Application
Priority
- US 2004002321 W 20040128
- US 44347803 P 20030129
Abstract (en)
[origin: WO2004067721A2] Human TKT genes are identified as modulators of the beta-catenin pathway, and thus are therapeutic targets for disorders associated with defective beta-catenin function. Methods for identifying modulators of beta-catenin, comprising screening for agents that modulate the activity of TKT are provided.
IPC 1-7
IPC 8 full level
C12N 5/07 (2010.01); C12N 5/09 (2010.01); C12N 9/10 (2006.01); C12Q 1/48 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C12N 9/1022 (2013.01); C12Q 1/48 (2013.01); C12Y 202/01001 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
AL LT LV MK
DOCDB simple family (publication)
WO 2004067721 A2 20040812; WO 2004067721 A3 20061214; AU 2004207272 A1 20040812; CA 2513601 A1 20040812; EP 1587911 A2 20051026; EP 1587911 A4 20070912; JP 2007524355 A 20070830
DOCDB simple family (application)
US 2004002321 W 20040128; AU 2004207272 A 20040128; CA 2513601 A 20040128; EP 04706014 A 20040128; JP 2006503093 A 20040128